Changes to UK ODA research funding including the Ross Fund Portfolio. Dr Sue Kinn Head Health Research Research and Evidence Division June 2017

Transcription

1 Changes to UK ODA research funding including the Ross Fund Portfolio Dr Sue Kinn Head Health Research Research and Evidence Division June 2017

2 UK Aid Strategy Nov Strengthening global peace, security and governance 2 Strengthening resilience and response to crises 3 Promoting global prosperity 4 Tacking extreme poverty and helping the world s most vulnerable

3 ODA funded research Focus on development challenges Multi-disciplinary Attracting new research teams/ideas to the field Must show value for money Must be in line with UK Aid strategy Can be investigated by Independent Commission on Aid Impact (ICAI) Must qualify for classification as ODA (OECD-DAC definitions)

4 ODA research funds DFID research including Ross Fund Portfolio DH ODA research Ross Fund Portfolio and NIHR Global Challenges Research Fund (GCRF) through BEIS Newton Fund through BEIS

5 What should research teams think about Addressing key development challenges Traction in the countries where research is taking place Wider range of partners with focus on impact Should policy makers or others be involved How to work across disciplines Is the work going to deliver value for money How to be a good partner/collaborator

6 The DFID Research Review Launched on 26 th October Focuses on DFID s areas of comparative advantage Complementary to other research funds

7 DFID health research portfolio Infectious diseases Product development (drugs, diagnostics, vaccines, other) Implementation research Clinical trials Sexual, reproductive, maternal, newborn, child health Product development Implementation research Clinical trials Health systems strengthening Implementation research Non communicable diseases Implementation research Clincial trials

8 Ross Fund Portfolio - 1bn announced November 2015 to tackle the world s deadliest diseases including: epidemic diseases, neglected tropical diseases and diseases with emerging resistance (including AMR) DFID New products for infectious diseases New products for diseases with emerging resistance New products for neglected tropical diseases Research and development of new products for diseases of epidemic potential Implementation programmes for malaria and NTDs Dept of Health (DH) UK vaccine R&D network Rapid response team GSK bio-preparedness organisation Fleming fund AMR global innovation fund

9 What is the Ross Fund Portfolio? It is not a fund It is a way of describing the UK Government investments in three areas: Diseases of epidemic potential Neglected Tropical Diseases Diseases with emerging resistance, including AMR It is a mixture of research and implementation Not all UK Govt work in these three areas is within the Ross Fund Portfolio You can t bid for funding designated as Ross Fund There will be funding opportunities for some areas covered

10 DFID Ross Fund Portfolio research opportunities Product development research Health systems resilience Implementation research for infectious diseases Epidemic responsiveness research

11 How to find out about research calls DFID website Funding tracker alerts Development tracker Twitter accounts and team specific Partner websites UKCDS and other websites

12 DFID funding modalities Product Development e.g. PDPs or orgnaisations managing a portfolio of candidates Research Programme Consortia (RPCs) Responsive programmes with MRC/ESRC/Wellcome and DH Through global health research programmes at WHO Other consortia

13 DH Ross Fund Portfolio UK Vaccine R&D Network has had calls and likely to have some more Rapid response team was awarded following a competition, moving into implementation Fleming fund awarded following competition, moving into implementation AMR global innovation fund still being designed but likely to be open to competition

14 DH other ODA research funding Initially focused on Non Communicable Disease, now much wider Spending through NIHR Open to researchers in all four of the UK countries

15 Different funding streams

16 GCRF Research Agenda for Enabling Change Support excellent research that directly contributes to the sustainable and inclusive prosperity of people in developing countries. It addresses the ambitions and aspirations of the SDGs and underpins the UK aid strategy Overarching framework: Leave no one behind Sustainable economies and societies Support peace and justice Spend through Research Councils and learned bodies (BEIS)

17 Vision Create new knowledge and drive innovation that helps to ensure that everyone across the globe has access to: secure and resilient food systems supported by sustainable marine resources and agriculture sustainable health and well being inclusive and equitable quality education clean air, water and sanitation affordable, reliable, sustainable energy

18 Newton Fund ( million) (BEIS) To promote the economic development and social welfare of either the partner countries or, through working with the partner country, to address the well being of communities. It strengthens partner country science and innovation capacity and unlocks further funding to support this work Delivered through 15 UK partners that develop and run calls, and allocate and manage the funding 3 broad activities: People: increasing capacity in science and innovation, individually and institutionally in partner countries Research: research collaborations on development topics Translation: creating collaborative solutions to development challenges and strengthening innovation systems

19 Official Development Assistance (ODA) Key measure used in most aid targets and assessments of aid performance Definition agreed in 1969 by the OECD Development Assistance Committee (DAC) In 1970 most DAC members agreed to long term objective of spending 0.7% of GNI on ODA In 2004 UK set itself the target to achieve 0.7% by 2013 Detailed programme-level data scrutinised and published by the OECD

20 Considering ODA eligibility An official flow ODA eligible country/institution Primary purpose Detailed directives The DAC has produced Directives, list of eligible countries and organisations and other guidance to help understand what is ODA

21 Ask yourselves Is it consistent with the UK approach? Is it consistent with international best practice? Is it credible? ICAI IDC Role of Statisticians / UKSA NAO Credibility of UK ODA OECD publish project level data

22 ... And finally More information at: More information about research funded by DFID at: